CYY292
CYY292 is an FGFR1 inhibitor that specifically targets the FGFR1/AKT/Snail pathway in GBM cells. CYY292 dose-dependently inhibits cancer cell proliferation, epithelial-mesenchymal transition, stemness, invasion, and migration in vitro[1].
Product Specifications
CAS Number
[2644673-04-9]
UNSPSC
12352005
Target
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cyy292.html
Purity
99.19
Solubility
10 mM in DMSO
Smiles
CN1CCN(C2=C(OC)C=C(NC3=NC(NC4=CC(NN=C5)=C5C=C4)=C(C)C=N3)C=C2)CC1
Molecular Formula
C24H28N8O
Molecular Weight
444.53
References & Citations
[1]Bi Y, et al. A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis. Genes Dis. 2023 Apr 3;11 (1) :479-494.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Rabbit Polyclonal OR6T1 Antibody [Biotin]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
147159 50 µg
TMC6, Control Peptide (Transmembrane Channel-Like Protein 6, Epidermodysplasia Verruciformis Protein 1, Protein LAK-4, EVER1, EVIN1)
Ask
View Details W1006-05-ML405 100 µL
WDR1, CT (WD Repeat-containing Protein 1, Actin-interacting Protein 1, AIP1, NORI-1) (MaxLight 405) discontinued
Ask
View Details 